Triethylamine-Mediated Protonation–Deprotonation Unlocks Dual-Drug Self Assembly to Suppress Breast Cancer Progression and Metastasis

Scientists emphasized the significant clinical potential of DT as an innovative carrier-free nanomedicine and provided profound insights into the design of nanomedicines for cancer therapy.